Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
By James Swann
April 7 — The Centers for Medicare & Medicaid Services imposed a $1 million civil money penalty on Aetna Inc. for falsely identifying in-network pharmacies to beneficiaries enrolling in Medicare Advantage and Medicare Part D drug plans for 2015.
Aetna will have until June 2 to request a hearing before the Department of Health and Human Services Departmental Appeals Board to appeal the CMP.
If it doesn't request a hearing, the $1 million payment is due June 3.
According to the CMS, 6,887 non-network retail pharmacies were listed as network pharmacies on Aetna's website, and customer service representatives also provided the false information to beneficiaries.
“After January 1, 2015, many Aetna enrollees presented with a prescription at their usual pharmacy only to discover that the pharmacy was not in their plan’s network,” the April 2 CMP notice from the CMS said.
As a result, many beneficiaries were either forced to pay cash for their prescriptions or left the pharmacy without them, the CMS said.
In an April 7 statement, John Norton, a spokesman with the National Community Pharmacists Association (NCPA), said seniors, caregivers and pharmacists were affected by “avoidable glitches.”
“As CMS noted in its letter, beneficiary complaints about these plans were five times greater than that of all other plan sponsors during the same time period and 73 percent of the complaints centered on misleading marketing about in-network pharmacy coverage,” Norton said.
The falsely identified pharmacies were initially uncovered by the NCPA, which began hearing about the issue from member pharmacies in January.
A representative from Aetna didn't immediately respond to an April 7 request for comment on the CMP.
Beneficiaries affected by the misidentified pharmacies were given a special enrollment period to disenroll from their Aetna plan and enroll in an alternative Medicare Part D plan, the notice said.
“This issue of non-compliance directly adversely impacted thousands of beneficiaries and had the substantial likelihood of impacting all Medicare beneficiaries enrolled in Aetna plans with incorrect pharmacy listings,” the CMS said.
In addition to imposing the CMP, the CMS notice said Aetna accounted for 33 percent (3,767) of all complaints received regarding Medicare Advantage drug plan and Medicare Part D issues.
Of the complaints against Aetna, 73 percent alleged that beneficiaries were given the wrong information about network pharmacies within Aetna plans.
To contact the reporter on this story: James Swann in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Kendra Casey Plank at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)